Lannett Company, Inc. (LCI) Stake Maintained by Public Sector Pension Investment Board
Public Sector Pension Investment Board held its position in Lannett Company, Inc. (NYSE:LCI) during the fourth quarter, according to its most recent filing with the SEC. The firm owned 20,605 shares of the company’s stock at the end of the fourth quarter. Public Sector Pension Investment Board owned about 0.06% of Lannett Company worth $454,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the company. BlackRock Fund Advisors increased its position in Lannett Company by 7.4% in the third quarter. BlackRock Fund Advisors now owns 2,197,926 shares of the company’s stock valued at $58,399,000 after buying an additional 150,901 shares in the last quarter. Snow Capital Management LP increased its position in Lannett Company by 159.9% in the third quarter. Snow Capital Management LP now owns 1,638,072 shares of the company’s stock valued at $43,524,000 after buying an additional 1,007,907 shares in the last quarter. State Street Corp increased its position in Lannett Company by 13.7% in the fourth quarter. State Street Corp now owns 1,186,674 shares of the company’s stock valued at $26,169,000 after buying an additional 142,616 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Lannett Company by 3.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 966,777 shares of the company’s stock valued at $21,318,000 after buying an additional 28,904 shares in the last quarter. Finally, Thompson Siegel & Walmsley LLC increased its position in Lannett Company by 37.3% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 901,729 shares of the company’s stock valued at $19,883,000 after buying an additional 244,974 shares in the last quarter. 80.82% of the stock is currently owned by hedge funds and other institutional investors.
Lannett Company, Inc. (NYSE:LCI) opened at 20.55 on Tuesday. Lannett Company, Inc. has a 52 week low of $16.75 and a 52 week high of $39.99. The stock’s market capitalization is $764.23 million. The firm’s 50-day moving average is $21.63 and its 200-day moving average is $23.72.
Lannett Company (NYSE:LCI) last announced its quarterly earnings data on Wednesday, February 1st. The company reported $0.92 EPS for the quarter, topping the Zacks’ consensus estimate of $0.84 by $0.08. The company earned $171 million during the quarter, compared to the consensus estimate of $169.04 million. Lannett Company had a negative net margin of 3.48% and a positive return on equity of 21.95%. Lannett Company’s quarterly revenue was up 34.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.95 EPS. On average, equities research analysts predict that Lannett Company, Inc. will post $3.44 EPS for the current fiscal year.
Your IP Address:
Several equities analysts have recently weighed in on LCI shares. Zacks Investment Research raised shares of Lannett Company from a “sell” rating to a “buy” rating and set a $21.00 price target on the stock in a research note on Thursday, January 26th. Roth Capital set a $28.00 price target on shares of Lannett Company and gave the stock a “buy” rating in a research note on Thursday, February 2nd. Finally, Oppenheimer Holdings Inc. reissued a “hold” rating on shares of Lannett Company in a research note on Tuesday, December 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $28.71.
In other news, CEO Arthur P. Bedrosian acquired 10,000 shares of the business’s stock in a transaction on Monday, February 6th. The stock was bought at an average price of $20.00 per share, for a total transaction of $200,000.00. Following the transaction, the chief executive officer now owns 688,909 shares in the company, valued at $13,778,180. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 15.04% of the stock is currently owned by corporate insiders.
Lannett Company Company Profile
Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.
Want to see what other hedge funds are holding LCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lannett Company, Inc. (NYSE:LCI).
Receive News & Ratings for Lannett Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.